Anthropic-Adaptyv Protein Design Competition Round 3 Targets GLP1R Activation

Anthropic and Adaptyv launched round 3 of their protein design competition, asking participants to design proteins that activate the GLP1R receptor, the target of semaglutide and tirzepatide. The round introduces cell-based activation measurements, marking a harder GPCR agonist design challenge.

2026-10-13 ~ 2026-10-13 · 3 related posts

• Anthropic × Adaptyv protein design challenge 3 targets GLP1R, the Ozempic receptor — AllThingsApx · 2026-10-13
• Anthropic × Adaptyv protein contest opens GLP-1R agonist challenge, extended to two weeks — nc_frey · 2026-10-13

1 near-duplicate retellings: victorgreiff